Sugi Holdings (Sugi Pharmacy)

Major retail groups · 7649

The Japan read

From the company's own filing for H1 (Mar–Aug 2026) · reported 2026-10-08 · the filing

JapanSugi Pharmacy's same-store sales rose 4.4% in the half: customer numbers fell 1.2% and spend per customer rose 5.6%. Merchandise sales at existing drugstores rose 2.5% and prescription sales 9.4% (company figures, excluding subsidiaries).
StoresIt opened 60 stores, closed 21 and refurbished 92 in the half, ending August with 2,360 outlets. On 1 September it raised its stake in Seki Yakuhin, a drugstore and pharmacy chain, to 51.0%, making it a subsidiary.

Other callouts in the filing

One-offNet income fell 54.6% because the year-earlier half included deferred tax assets, mainly for tax losses carried forward, booked when it absorbed the former I&H; tax went from a ¥6.29bn credit to an ¥8.04bn charge.
OutlookIt raised full-year sales guidance to ¥1,117.9bn (+10.6%) from ¥1,092.0bn by adding Seki Yakuhin from September, but cut operating profit to ¥51.0bn (+5.0%) from ¥54.0bn and net income to ¥27.4bn (−39.1%) from ¥32.8bn, citing weak summer seasonal sales in poor weather.

floortok's reading of the filing, in our own words. Figures are the company's own; where a growth rate is our arithmetic, it says so.

Show figures in

H1 (Mar–Aug 2026) · Year-to-Date

Reported 2026-10-08

Net sales¥540.7bn+8.1%

Operating profit¥24.7bn+4.4%

Net income¥13.0bn−54.6%

Sugi Holdings runs the Sugi Pharmacy drugstore and dispensing chain — 2,360 outlets at end-August, with new stores concentrated in Kanto, Chubu and Kansai. In March–August 2026 net sales rose 8.1% to ¥540.7bn and operating profit 4.4% to ¥24.7bn, while net income fell 54.6% to ¥13.0bn against a one-off tax gain a year earlier.